Retatrutide has emerged as a new treatment in the fight against obesity. This revolutionary drug, classified as a dual GLP-1 and GIP receptor agonist, demonstrates promising results in investigations. By stimulating https://leaerzv430887.getblogs.net/68757748/tirzepatide-a-promising-new-treatment-for-obesity